CTMX vs GOOGL · rev $11.7M vs P/E 26, rev $229.69B
CytomX Therapeutics Inc (CTMX) versus Alphabet Inc Class A (GOOGL) — a side-by-side from cached financials, not a winner call.
CytomX Therapeutics Inc (CTMX) is a biotechnology company listed on US.
Alphabet Inc Class A (GOOGL) is a internet content & information company listed on US. It is led by Sundar Pichai.
Latest reported CTMX revenue for 2026-06-30 was $11.7M. Net income was -$38.9M. Revenue was up 13.8% from 2026-03-31 to 2026-06-30. CTMX currently screens at market cap $653.1M.
Latest reported GOOGL revenue for 2026-06-30 was $229.69B. Net income was $174.77B. Revenue was up 23.1% from 2025-06-30 to 2026-06-30. GOOGL currently screens at market cap $2.97T and trailing P/E 26.1.
CTMX currently screens at market cap $653.1M. GOOGL currently screens at market cap $2.97T and trailing P/E 26.1.
Not investment advice. Open the CTMX and GOOGL stock pages for the full models.
Not investment advice.